Inorganic phosphate and the risk of cancer in the Swedish AMORIS study

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Wulaningsih, Wahyu ^a   Michaelsson, Karl ^b   Garmo, Hans ^a,c   Hammar, Niklas ^d,e   Jungner, Ingmar ^d   Walldius, Göran ^d   Holmberg, Lars ^a,c   Van Hemelrijck, Mieke ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

Cancer; Inorganic phosphate; Prospective cohort study

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CREATININE; GLUCOSE; PHOSPHATE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLADDER CANCER; BONE CANCER; BRAIN CANCER; BREAST CANCER; CALCIUM BLOOD LEVEL; CANCER LOCALIZATION; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ENDOCRINE TUMOR; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; FEMALE; GALLBLADDER CANCER; GLUCOSE BLOOD LEVEL; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MALE; MELANOMA SKIN CANCER; MULTIPLE MYELOMA; NON MELANOMA SKIN CANCER; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PATIENT SELECTION; PHOSPHATE BLOOD LEVEL; POPULATION RESEARCH; PROSTATE CANCER; SOFT TISSUE CANCER; STOMACH CANCER; SWEDISH APOLIPOPROTEIN MORTALITY RISK; TESTIS CANCER; THYROID CANCER; TYPES OF STUDY; BLOOD; COHORT ANALYSIS; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SWEDEN;

ADULT; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PHOSPHATES; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SWEDEN;

EID: 84878010285     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-257     Document Type: Article

References (48)

1. Randi G, Edefonti V, Ferraroni M, La Vecchia C, Decarli A. Dietary patterns and the risk of colorectal cancer and adenomas. Nutr Rev 2010, 68(7):389-408. 10.1111/j.1753-4887.2010.00299.x, 20591107.
2. Takeda E, Yamamoto H, Nashiki K, Sato T, Arai H, Taketani Y. Inorganic phosphate homeostasis and the role of dietary phosphorus. J cellular and molecular med 2004, 8(2):191-200.
3. Conrads KA, Yi M, Simpson KA, Lucas DA, Camalier CE, Yu LR, Veenstra TD, Stephens RM, Conrads TP, Beck GR. A combined proteome and microarray investigation of inorganic phosphate-induced pre-osteoblast cells. Molecular & cellular proteomics : MCP 2005, 4(9):1284-1296. 10.1074/mcp.M500082-MCP200, 3660475, 23705109.
4. Chang SH, Yu KN, Lee YS, An GH, Beck GR, Colburn NH, Lee KH, Cho MH. Elevated inorganic phosphate stimulates Akt-ERK1/2-Mnk1 signaling in human lung cells. American J Respiratory Cell and Molecular Biology 2006, 35(5):528-539.
5. Camalier CE, Young MR, Bobe G, Perella CM, Colburn NH, Beck GR. Elevated phosphate activates N-ras and promotes cell transformation and skin tumorigenesis. Cancer Prev Res (Phila) 2010, 3(3):359-370.
6. Jin H, Chang SH, Xu CX, Shin JY, Chung YS, Park SJ, Lee YS, An GH, Lee KH, Cho MH. High dietary inorganic phosphate affects lung through altering protein translation, cell cycle, and angiogenesis in developing mice. Toxicological sciences : an official journal of the Society of Toxicology 2007, 100(1):215-223.
7. Jin H, Hwang SK, Kwon JT, Lee YS, An GH, Lee KH, Prats AC, Morello D, Beck GR, Cho MH. Low dietary inorganic phosphate affects the brain by controlling apoptosis, cell cycle and protein translation. The J Nutritional Biochemistry 2008, 19(1):16-25.
8. Shutto Y, Shimada M, Kitajima M, Yamabe H, Razzaque MS. Lack of awareness among future medical professionals about the risk of consuming hidden phosphate-containing processed food and drinks. PLoS One 2011, 6(12):e29105. 10.1371/journal.pone.0029105, 3248402, 22220204.
9. Benini O, D'Alessandro C, Gianfaldoni D, Cupisti A. Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients. J Ren Nutr 2011, 21(4):303-308. 10.1053/j.jrn.2010.06.021, 21055967.
10. Bansal VK. Serum Inorganic Phosphorus. Clinical Methods: The History, Physical, and Laboratory Examinations 1990, Boston, Walker HK, Hall WD, Hurst JW, 3.
11. Tan HL, Liew QY, Loo S, Hawkins R. Severe hyperphosphataemia and associated electrolyte and metabolic derangement following the administration of sodium phosphate for bowel preparation. Anaesthesia 2002, 57(5):478-483. 10.1046/j.0003-2409.2001.02519.x, 11966559.
12. Jin H, Hwang SK, Yu K, Anderson HK, Lee YS, Lee KH, Prats AC, Morello D, Beck GR, Cho MH. A high inorganic phosphate diet perturbs brain growth, alters Akt-ERK signaling, and results in changes in cap-dependent translation. Toxicol Sci 2006, 90(1):221-229.
13. Ditzel J, Lervang HH. Disturbance of inorganic phosphate metabolism in diabetes mellitus: its impact on the development of diabetic late complications. Curr Diabetes Rev 2010, 6(5):323-333. 10.2174/157339910793360833, 20701584.
14. Tiosano D, Hochberg Z. Hypophosphatemia: the common denominator of all rickets. J Bone and Mineral Metabolism 2009, 27(4):392-401.
15. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J internal medicine 2009, 266(6):558-570.
16. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J internal medicine 2009, 265(2):275-287.
17. Jungner I, Sniderman AD, Furberg C, Aastveit AH, Holme I, Walldius G. Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?. Am J Cardiol 2006, 97(7):943-946. 10.1016/j.amjcard.2005.10.062, 16563891.
18. Statistics Sweden http://www.scb.se/.
19. Gamst O, Try K. Determination of serum-phosphate without deproteinization by ultraviolet spectrophotometry of the phosphomolybdic acid complex. Scand J Clin Lab Invest 1980, 40(5):483-486. 10.3109/00365518009101872, 7444350.
20. Alonso GL, Tumilasci OR, Nikonov JM. Improvement of a direct colorimetric method for calcium determination. Clin Chim Acta 1970, 27(3):549-551. 10.1016/0009-8981(70)90310-4, 5435235.
21. Pawar GB, Todai NK, Jaffar MB. A useful modification to the colorimetric assay of inorganic phosphorus and alkaline phosphatase in serum. Clin Chem 1978, 24(10):1847-1848.
22. Purcell GV, Behenna DB, Walsh PR. Evaluation of the BMC glucose oxidase/peroxidase-4-aminophenazone-phenol procedure for glucose as adapted to the Technicon SMAC. Clin Chem 1979, 25(10):1844-1846.
23. Shoucri RM, Pouliot M. Some observations on the kinetics of the Jaffe reaction for creatinine. Clin Chem 1977, 23(9):1527-1530.
24. Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem 1998, 44(8 Pt 1):1641-1649.
25. Ogunleye AA, Ogston SA, Morris AD, Evans JM. A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 2009, 101(7):1199-1201. 10.1038/sj.bjc.6605240, 2768085, 19690547.
26. Williams CD, Whitley BM, Hoyo C, Grant DJ, Schwartz GG, Presti JC, Iraggi JD, Newman KA, Gerber L, Taylor LA. Dietary calcium and risk for prostate cancer: a case-control study among US veterans. Prev Chronic Dis 2012, 9:E39. 3310142, 22239754.
27. Shoback D. Update in osteoporosis and metabolic bone disorders. J Clin Endocrinol Metab 2007, 92(3):747-753.
28. Rollison DE, Cole AL, Tung KH, Slattery ML, Baumgartner KB, Byers T, Wolff RK. Giuliano 2011, Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast cancer research and treatment: AR.
29. Bergwitz C, Juppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 2010, 61:91-104. 10.1146/annurev.med.051308.111339, 20059333.
30. Michaelsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundstrom J, Berglund L, Arnlov J, Hellman P, Blomhoff R. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010, 92(4):841-848. 10.3945/ajcn.2010.29749, 20720256.
31. Murer H, Biber J. Phosphate transport in the kidney. J Nephrol 2010, 23(Suppl 16):S145-151.
32. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999, 354(9173):93-99. 10.1016/S0140-6736(99)06154-1, 10408483.
33. Gally F, Chu HW, Bowler RP. Cigarette Smoke Decreases Airway Epithelial FABP5 Expression and Promotes Pseudomonas aeruginosa Infection. PLoS One 2013, 8(1):e51784. 10.1371/journal.pone.0051784, 3551956, 23349676.
34. Carpenter TO. Oncogenic osteomalacia-a complex dance of factors. N Eng J Med 2003, 348(17):1705-1708.
35. Newmark HL, Lipkin M, Maheshwari N. Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet. J National Cancer Institute 1990, 82(6):491-496.
36. Jin H, Xu CX, Lim HT, Park SJ, Shin JY, Chung YS, Park SC, Chang SH, Youn HJ, Lee KH. High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling. Am J Respir Crit Care Med 2009, 179(1):59-68. 10.1164/rccm.200802-306OC, 2615662, 18849498.
37. Xu CX, Jin H, Lim HT, Ha YC, Chae CH, An GH, Lee KH, Cho MH. Low dietary inorganic phosphate stimulates lung tumorigenesis through altering protein translation and cell cycle in K-ras(LA1) mice. Nutr Cancer 2010, 62(4):525-532. 10.1080/01635580903532432, 20432174.
38. Miltiadous G, Christidis D, Kalogirou M, Elisaf M. Causes and mechanisms of acid-base and electrolyte abnormalities in cancer patients. Eur J Intern Med 2008, 19(1):1-7. 10.1016/j.ejim.2007.04.016, 18206594.
39. Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005, 365(9470):1543-1551.
40. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288(3):321-333. 10.1001/jama.288.3.321, 12117397.
41. Uemura H, Irahara M, Yoneda N, Yasui T, Genjida K, Miyamoto KI, Aono T, Takeda E. Close correlation between estrogen treatment and renal phosphate reabsorption capacity. J Clin Endocrinol Metab 2000, 85(3):1215-1219. 10.1210/jc.85.3.1215, 10720065.
42. Cawthon PM, Parimi N, Barrett-Connor E, Laughlin GA, Ensrud KE, Hoffman AR, Shikany JM, Cauley JA, Lane NE, Bauer DC. Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metab 2010, 95(10):4625-4634. 10.1210/jc.2010-0638, 3050100, 20631024.
43. Jacobs E, Martinez ME, Buckmeier J, Lance P, May M, Jurutka P. Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma. J Carcinog 2011, 10:3. 10.4103/1477-3163.76723, 3049272, 21383962.
44. Mulholland HG, Murray LJ, Anderson LA, Cantwell MM. Vitamin D, calcium and dairy intake, and risk of oesophageal adenocarcinoma and its precursor conditions. Br J Nutr 2011, 106(5):732-741. 10.1017/S0007114511000742, 21736847.
45. Laitman Y, Kuchenbaecker KB, Rantala J, Hogervorst F, Peock S, Godwin AK, Arason A, Kirchhoff T, Offit K, Isaacs C. The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2012, 132(3):1119-1126. 10.1007/s10549-011-1938-8, 3352679, 22212556.
46. Van Hemelrijck M. Thesis for doctoral degree (PhD). Metabolic Syndrome and Prostate Cancer: Biomarkers and Treatment Side-effects 2010, London: King's College London.
47. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB, Gaziano JM, Vasan RS. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007, 167(9):879-885. 10.1001/archinte.167.9.879, 17502528.
48. Larsson TE, Olauson H, Hagstrom E, Ingelsson E, Arnlov J, Lind L, Sundstrom J. Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community. Arterioscler Thromb Vasc Biol 2010, 30(2):333-339. 10.1161/ATVBAHA.109.196675, 19948843.